Language Switcher

Borsisti Progetto UniRoma-Pharma-Training (2004-2005)

Valeria Angelini (GlaxoSmithKline, Harlow, United Kingdom)
Alessandro Annibaldi (Celltech R&D Ltd, Cambridge, United Kingdom)
Daniele Battaglia (Eli Lilly & Co. Ltd, Windlesham, United Kingdom)
Micol Bellucci (BBV Bretagne Biotechnologie Végétale, Saint Pol de Léon, France)
Antonio Berretta (Neuropharma, Madrid, Spain)
Giacomo Berretta (Novartis Institute for Medical Sciences, London, United Kingdom)
Alessia Bianchi (Glaxo Smith Kline, Harlow, United Kingdom)
Paolo Brandi (Sanofi Aventis Deutschland GmbH, Frankfurt, United Kingdom)
Antonello Calcutta (Fraunhofer Institute , Hannover, Germany)
Claudia Compagnucci (Eli Lilly & Co. Ltd, Windlesham, United Kingdom)
Domenico Cosentino (Bayer , Monheim, Germany)
Maria Letizia Cucchiaroni (Eli Lilly & Co. Ltd, Windlesham, United Kingdom)
Livia Curcio (Novartis Institute for Medical Sciences, London, United Kingdom)
Paolo De Bona (PR euroCHEM Ltd, Cork, Ireland)
Sara De Grazia (Neuropharma, Madrid, Spain)
Claudia Fabiani (Instituto Oftalmologico Alicante, Alicante, Spain)
Francesco Fazio (Cyprotex Discovery, Cheshire, United Kingdom)
Danila Fazio (Coley Pharmaceutical GmbH, Langenfeld, Germany)
Filomena Maria Festa (Neuropharma, Madrid, Spain)
Marco Genua (Baxter Bioscience, Vienna, Austria)
Anna Ghazaryan (Eli Lilly & Co. Ltd, Windlesham, United Kingdom)
Alessandro Lanza (Eli Lilly & Co. Ltd, Windlesham, United Kingdom)
Mariaelisa Manganaro (Sanofi Aventis Deutschland GmbH, Frankfurt, Germany)
Francesca Masciopinto (Instituto Oftalmologico Alicante, Alicante, Spain)
Raffaella Nativio (GlaxoSmithKline, Stevenage, United Kingdom)
Irene Angela Pappalardo (PR euroCHEM Ltd, Cork, Ireland)
Cristina Pierro (Karolinska Institutet, Stockholm, Sweden)
Alessandro Pristerà (Novartis Institute for Medical Sciences, London, United Kingdom)
Davide Privitera (Organon Akzo Nobel, Oss, The Netherlands)
Anna Rapisarda (GlaxoSmithKline, Harlow, United Kingdom)
Raffaella Ricci (Celltech R&D Ltd, Cambridge, United Kingdom)
Simonetta Santini (Baxter Bioscience, Vienna, Austria)
Marta Scandurra (Novartis Pharmaceuticals, Horsham Research Centre, Horsham, United Kingdom)
Chiara Secondini (Sanofi Aventis Deutschland GmbH, Frankfurt, United Kingdom)
Lorena Serpilli (Eli Lilly & Co. Ltd, Windlesham, United Kingdom)
Marylinda Sipala (Dominion Pharmakine, Derio, Spain)
Giusy Sirico (Astrazeneca, Loughborough, United Kingdom)
Patrizia Tedeschi (Karolinska Institutet, Stockholm, Sweden)
Valentina Tesori (Pierre Fabre, Castres, France)
Francesca Tinti (Neutec Pharma, Manchester, United Kingdom)
Roberta Torge (Sanofi Aventis Deutschland GmbH, Frankfurt, Germany)